NO174803C - - Google Patents

Info

Publication number
NO174803C
NO174803C NO911746A NO911746A NO174803C NO 174803 C NO174803 C NO 174803C NO 911746 A NO911746 A NO 911746A NO 911746 A NO911746 A NO 911746A NO 174803 C NO174803 C NO 174803C
Authority
NO
Norway
Application number
NO911746A
Other languages
Norwegian (no)
Other versions
NO911746L (no
NO911746D0 (no
NO174803B (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO911746D0 publication Critical patent/NO911746D0/no
Publication of NO911746L publication Critical patent/NO911746L/no
Publication of NO174803B publication Critical patent/NO174803B/no
Publication of NO174803C publication Critical patent/NO174803C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO911746A 1990-05-04 1991-05-03 Enantiomerseparasjon av Cimaterol NO174803B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (4)

Publication Number Publication Date
NO911746D0 NO911746D0 (no) 1991-05-03
NO911746L NO911746L (no) 1991-11-05
NO174803B NO174803B (no) 1994-04-05
NO174803C true NO174803C (en:Method) 1994-07-13

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911746A NO174803B (no) 1990-05-04 1991-05-03 Enantiomerseparasjon av Cimaterol

Country Status (27)

Country Link
US (4) US5248695A (en:Method)
EP (2) EP0455155B1 (en:Method)
JP (1) JP2944777B2 (en:Method)
KR (1) KR0183024B1 (en:Method)
AR (1) AR247728A1 (en:Method)
AT (2) ATE158277T1 (en:Method)
AU (1) AU645313B2 (en:Method)
BG (1) BG60743B1 (en:Method)
CA (1) CA2041818C (en:Method)
CZ (1) CZ286389B6 (en:Method)
DE (3) DE4014252A1 (en:Method)
DK (2) DK0589488T3 (en:Method)
ES (2) ES2109412T3 (en:Method)
FI (1) FI109600B (en:Method)
GR (2) GR3017064T3 (en:Method)
HU (1) HU214335B (en:Method)
ID (1) ID966B (en:Method)
IE (2) IE69017B1 (en:Method)
IL (1) IL98030A (en:Method)
NO (1) NO174803B (en:Method)
NZ (1) NZ238032A (en:Method)
PT (1) PT97544B (en:Method)
RU (1) RU2002737C1 (en:Method)
SG (1) SG45439A1 (en:Method)
SK (1) SK279258B6 (en:Method)
TW (1) TW197415B (en:Method)
ZA (1) ZA913337B (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
WO1997026871A1 (en) * 1996-01-29 1997-07-31 Savor, Evelyn Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
AU737608B2 (en) 1997-04-30 2001-08-23 Courage Corporation Pty Ltd Composition and methods using an eutomer
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
SK15382002A3 (sk) * 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
US20040235922A1 (en) * 2003-05-15 2004-11-25 Baile Clifton A. Compositions and methods for inducing adipose tissue cell death
DE602004010531T2 (de) * 2003-09-09 2008-07-03 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
MY147864A (en) 2005-04-13 2013-01-31 Astion Dev As Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
MY176727A (en) 2012-12-03 2020-08-20 Pfizer Selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (en:Method) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
KR0183024B1 (ko) 1999-05-15
ATE124932T1 (de) 1995-07-15
TW197415B (en:Method) 1993-01-01
CA2041818A1 (en) 1991-11-05
FI912151L (fi) 1991-11-05
CA2041818C (en) 2003-02-11
GR3025547T3 (en) 1998-03-31
JP2944777B2 (ja) 1999-09-06
IL98030A (en) 1995-12-31
CS129291A3 (en) 1991-11-12
SK279258B6 (sk) 1998-08-05
KR910019966A (ko) 1991-12-19
HU911502D0 (en) 1991-11-28
US5292753A (en) 1994-03-08
DK0589488T3 (da) 1998-05-04
AR247728A1 (es) 1995-03-31
ZA913337B (en) 1993-01-27
DE59108853D1 (de) 1997-10-23
US5395957A (en) 1995-03-07
US5248695A (en) 1993-09-28
IL98030A0 (en) 1992-06-21
JPH04225944A (ja) 1992-08-14
EP0589488B1 (de) 1997-09-17
PT97544A (pt) 1992-01-31
GR3017064T3 (en) 1995-11-30
ID966B (id) 1996-09-30
AU645313B2 (en) 1994-01-13
BG60743B1 (bg) 1996-02-29
ES2075255T3 (es) 1995-10-01
NZ238032A (en) 1996-02-27
FI912151A0 (fi) 1991-05-03
ATE158277T1 (de) 1997-10-15
NO911746L (no) 1991-11-05
DE59105957D1 (de) 1995-08-17
AU7611191A (en) 1991-11-07
EP0455155A1 (de) 1991-11-06
SG45439A1 (en) 1998-01-16
BG94342A (en) 1994-06-30
CZ286389B6 (cs) 2000-03-15
HUT60999A (en) 1992-11-30
IE911507A1 (en) 1991-11-06
FI109600B (fi) 2002-09-13
EP0455155B1 (de) 1995-07-12
DK0455155T3 (da) 1995-11-13
IE80651B1 (en) 1998-11-04
US5648386A (en) 1997-07-15
PT97544B (pt) 1998-08-31
HU214335B (hu) 1998-03-02
NO911746D0 (no) 1991-05-03
IE69017B1 (en) 1996-07-24
NO174803B (no) 1994-04-05
RU2002737C1 (ru) 1993-11-15
ES2109412T3 (es) 1998-01-16
EP0589488A1 (de) 1994-03-30
DE4014252A1 (de) 1991-11-07

Similar Documents

Publication Publication Date Title
DK0525049T3 (en:Method)
DE4190992T (en:Method)
DE4190889T (en:Method)
DE4190481T1 (en:Method)
EP0440166A3 (en:Method)
DE4191754T (en:Method)
DE4191061T (en:Method)
DE4192351T (en:Method)
EP0455376A3 (en:Method)
NO174803C (en:Method)
DE4191062T (en:Method)
DE4190714T (en:Method)
DE4191321T (en:Method)
DE4190357T (en:Method)
FR2668277B1 (en:Method)
FR2665774B1 (en:Method)
DE4192545T (en:Method)
JPH0489457U (en:Method)
DE4190938T (en:Method)
JPH0490961U (en:Method)
ECSM90431U (en:Method)
ECSM90430U (en:Method)
ECSM90514U (en:Method)
IN173894B (en:Method)
IN173577B (en:Method)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees